Insider Buying: Relmada Therapeutics (NASDAQ:RLMD) COO Purchases 90,000 Shares of Stock
Relmada Therapeutics, Inc. (NASDAQ:RLMD - Get Free Report) COO Paul Edward Kelly bought 90,000 shares of Relmada Therapeutics stock in a transaction that occurred on Wednesday, November 5th. The...